Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies

Basit Öğe Kaydı
dc.contributor.authorOzmen, Vahit
dc.contributor.authorBoylu, Sukru
dc.contributor.authorOk, Engin
dc.contributor.authorCanturk, Nuh Zafer
dc.contributor.authorCelik, Varol
dc.contributor.authorKapkac, Murat
dc.contributor.authorGirgin, Sadullah
dc.date.accessioned2024-04-24T17:08:05Z
dc.date.available2024-04-24T17:08:05Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground: One of the most important factors in breast cancer (BC) mortality is treatment delay. The primary goal of this survey was to identify factors affecting the total delay time (TDT) in Turkish BC patients. Methods: A total of 1031 patients with BC were surveyed using a uniform questionnaire. The time between discovering the first symptom and signing up for the first medical visit (patient delay time; PDT) and the time between the first medical visit and the start of therapy (system delay time; SDT) were modelled separately with multilevel regression. Results: The mean PDT, SDT and TDT were 4.8, 10.5 and 13.8 weeks, respectively. In all, 42% of the patients had a TDT >12 weeks. Longer PDT was significantly correlated with disregarding symptoms and having age of between 30 and 39 years. Shorter PDT was characteristic of patients who: had stronger self-examination habits, received more support from family and friends and had at least secondary education. Predictors of longer SDT included disregard of symptoms, distrust in success of therapy and medical system and having PDT in excess of 4 weeks. Shorter SDT was linked to the age of >60 years. Patients who were diagnosed during a periodic check-up or opportunistic mammography displayed shorter SDT compared with those who had symptomatic BC and their first medical examination was by a surgeon. Conclusion: TDT in Turkey is long and remains a major problem. Delays can be reduced by increasing BC awareness, implementing organized population-based screening programmes and founding cancer centres.en_US
dc.description.sponsorshipRoche Mustahzarlari San. A.S., Istanbul, Turkeyen_US
dc.description.sponsorshipThis study was supported by a grant from Roche Mustahzarlari San. A.S., Istanbul, Turkey.en_US
dc.identifier.doi10.1093/eurpub/cku086
dc.identifier.endpage14en_US
dc.identifier.issn1101-1262
dc.identifier.issn1464-360X
dc.identifier.issue1en_US
dc.identifier.pmid25096257
dc.identifier.scopus2-s2.0-84922441972
dc.identifier.scopusqualityQ1
dc.identifier.startpage9en_US
dc.identifier.urihttps://doi.org/10.1093/eurpub/cku086
dc.identifier.urihttps://hdl.handle.net/11468/17198
dc.identifier.volume25en_US
dc.identifier.wosWOS:000352013300004
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.ispartofEuropean Journal of Public Health
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keyword]en_US
dc.titleFactors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societiesen_US
dc.titleFactors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu